Previous 10 | Next 10 |
home / stock / glaxf / glaxf news
2024-01-09 18:04:24 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-01-09 14:38:04 ET GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference January 09, 2024 10:30 AM ET Company Participants Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer Tony Wood - Chief Scientific Officer Conference ...
2023-12-23 04:18:53 ET Summary AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. AbbVie's financials and forward outlook show strong performance alongside solid partnerships, which hint at growth potential. GSK's current financials, product la...
2023-12-13 12:51:53 ET Summary GSK's diversified portfolio and high dividend yield make it an attractive option for conservative value portfolios. The company's pipeline of drugs is improving, with a significant increase in drugs in clinical development and strong financial result...
2023-12-05 22:50:05 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-11-30 12:52:09 ET GSK plc (GSK) Getting Ahead of Respiratory Diseases Event with GSK Management Conference Call November 30, 2023 08:00 ET Company Participants Nick Stone - Investor Relations Tony Wood - Chief Scientific Officer Luke Miels - Chief Commercial...
2023-11-29 15:16:06 ET GSK plc (GSK) Redburn Atlantic CEO Conference November 29, 2023 04:00 AM ET Company Participants Luke Miels - Chief Commercial Officer Conference Call Participants Simon Baker - Redburn Presentation Simon Baker Good ...
2023-11-29 15:00:01 ET Summary Biogen's latest Alzheimer's drug, Aduhelm, faced challenges after FDA approval, leading to concerns about efficacy and high costs. Biogen and Eisai's latest FDA-approved lecanemab faces similar risks; as a result, shares are down over 20% year-over-y...
2023-11-29 12:33:02 ET GSK plc (GSK) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 07:30 AM ET Company Participants Jeff McLaughlin - Director, Investor Relations Philip Dormitzer - SVP and Global Head, Vaccines R&D and Infectious Disease Resear...
2023-11-10 14:23:48 ET Summary Lyell Immunopharma results from a phase 1 study using LYL797 for the treatment of relapsed/refractory NSCLC and TNBC patients with ROR1 expression expected in the 1st half of 2024. Results from phase 1 study using LYL845 for the treatment of patients...
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline Plc Company Name:
GLAXF Stock Symbol:
OTCMKTS Market:
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Color Ultrasonic Diagnostic Apparatus Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to ...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Chemical Mechanical Planarization Slurries Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the ...
New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Consumer Healthcare Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and ...